Medtronic's earnings beat estimates as sales of diabetes and heart devices rise
Medtronic ’s stock rose about 2 percent in afternoon trading after the company reported earnings that beat analyst expectations.
The medical-device giant’s adjusted profit in the fourth quarter reached $1.44 per share, 5 cents higher than Wall Street estimates. The company’s revenue climbed to $8.14 bi llion for the fourth quarter, up about 3 percent compared to the year-ago period.
Medtronic reported revenue growth across most of its business lines, with sales in its diabetes business leaping…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Katharine Grayson Source Type: news
More News: Cardiology | Diabetes | Endocrinology | Health Management | Heart | Medical Devices | Pharmaceuticals | Profits and Losses